RECRUITING

A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.

Official Title

A Culturally Tailored Scalable Asthma Intervention for Hispanic Children

Quick Facts

Study Start:2024-03-22

Study Completion:2025-05-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05892302

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:5 Years to 12 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:CHILD

Inclusion Criteria	Exclusion Criteria
1. Provision of signed and dated informed consent forms. 2. Who has a child who is 5-12 years of age 3. Whose child meets criteria for current persistent asthma defined as either: 1. On a long-term controller medication for asthma, or 2. Meet NAEPP guideline requirements for persistent disease:)(35) * Asthma symptoms 3 or more days per week over the past 2 weeks OR * Nocturnal asthma symptoms at least 3 times in the past month 4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months 5. Parent/Caregiver identifies as Mexican American or other Hispanic descent 6. Whose child has clinician diagnosed asthma 7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access) 8. Whose child is not currently participating in another asthma study.	* An individual who meets any of the following criteria will be excluded from participation in this study: 1. Unwilling to provide consent for research activities 2. Cognitive inability to provide consent 3. Whose child has evidence of other chronic lung or significant cardiovascular disease 4. Whose child has a history of intubation for asthma

Inclusion Criteria

Exclusion Criteria

1. Provision of signed and dated informed consent forms.
2. Who has a child who is 5-12 years of age
3. Whose child meets criteria for current persistent asthma defined as either:
1. On a long-term controller medication for asthma, or
2. Meet NAEPP guideline requirements for persistent disease:)(35)
* Asthma symptoms 3 or more days per week over the past 2 weeks OR
* Nocturnal asthma symptoms at least 3 times in the past month
4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months
5. Parent/Caregiver identifies as Mexican American or other Hispanic descent
6. Whose child has clinician diagnosed asthma
7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access)
8. Whose child is not currently participating in another asthma study.

* An individual who meets any of the following criteria will be excluded from participation in this study:
1. Unwilling to provide consent for research activities
2. Cognitive inability to provide consent
3. Whose child has evidence of other chronic lung or significant cardiovascular disease
4. Whose child has a history of intubation for asthma

Contacts and Locations

Study Contact

Susan Balcer Whaley, MPH

CONTACT

443-824-6107

susan.balcerwhaley@austin.utexas.edu

Christian Vallejo, MS

CONTACT

512-658-5877

christian.vallejo@austin.utexas.edu

Principal Investigator

Elizabeth Matsui, MD

PRINCIPAL_INVESTIGATOR

University of Texas at Austin

Study Locations (Sites)

University of Texas at Austin

Austin, Texas, 78712

United States

Collaborators and Investigators

Sponsor: University of Texas at Austin

Elizabeth Matsui, MD, PRINCIPAL_INVESTIGATOR, University of Texas at Austin

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-22

Study Completion Date2025-05-01

Study Record Updates

Study Start Date2024-03-22

Study Completion Date2025-05-01

Terms related to this study

Additional Relevant MeSH Terms

Asthma in Children